3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Recruiting
2
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Conditions
Neoplasms
4
Sarcoma
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Thymus Neoplasms
1
Sarcoma, Synovial
1
Prostatic Neoplasms
1
Multiple Myeloma
1
Mesothelioma
1
Meningioma
1
Melanoma
1
Liposarcoma
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Fatigue
1
Dermatofibrosarcoma
1
Cardiovascular Diseases
1
Carcinoma, Squamous Cell
1
Breast Neoplasms
1
Bone Neoplasms
1
Adenocarcinoma
1
Interventions
Doxorubicin
15
pembrolizumab
12
Surgical Procedures, Operative
8
Cyclophosphamide
8
Blood Specimen Collection
8
Ifosfamide
7
Gemcitabine
7
Surveys and Questionnaires
6
Nivolumab
6
Trabectedin
5
Radiotherapy
5
Magnetic Resonance Spectroscopy
5
Drug Therapy
5
atezolizumab
4
Temozolomide
4
Specimen Handling
4
Radiation Dose Hypofractionation
4
Biopsy
4
pazopanib
3
liposomal doxorubicin
3
fludarabine
3
cabozantinib
3
anlotinib
3
Radiation
3
Observation
3
Docetaxel
3
Dacarbazine
3
trastuzumab deruxtecan
2
toripalimab
2
selinexor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Sarcoma
×
Quality of Life
×
Clear all
NCT05051059
2026-03-16
QOLSarcoma
Universitaire Ziekenhuizen KU Leuven
Phase NA
Recruiting
60 enrolled
NCT07169344
2026-01-28
PROSARC-1
Oslo University Hospital
Phase 2
Recruiting
110 enrolled